Suppliers and packagers for cordran

cordran

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Ina Pharms	CORDRAN	flurandrenolide	OINTMENT;TOPICAL	012806	NDA	INA Pharmaceutics, Inc	74157-130-07	1 TUBE in 1 CARTON (74157-130-07) / 120 g in 1 TUBE	2025-07-07
Ina Pharms	CORDRAN	flurandrenolide	OINTMENT;TOPICAL	012806	NDA	INA Pharmaceutics, Inc	74157-180-60	1 TUBE in 1 CARTON (74157-180-60) / 60 g in 1 TUBE	2025-07-07
Almirall	CORDRAN	flurandrenolide	TAPE;TOPICAL	016455	NDA	Almirall, LLC	16110-587-24	1 BOTTLE in 1 CARTON (16110-587-24) / 450 cm2 in 1 BOTTLE	2018-09-24
Almirall	CORDRAN	flurandrenolide	TAPE;TOPICAL	016455	NDA	Almirall, LLC	16110-587-80	1 BOTTLE in 1 CARTON (16110-587-80) / 1500 cm2 in 1 BOTTLE	2018-09-24

Suppliers and packagers for cordran

Last updated: June 5, 2026

Cordran (Flurandrenolide) Suppliers: Who Manufactures It, Who Supplies APIs/Finishing, and What to Source for Generic/Store-Brand Entry

Cordran is a flurandrenolide topical corticosteroid product line. The practical sourcing answer for “suppliers” splits into three buckets: (1) the branded product manufacturer/labeler for the finished drug (NDC-level), (2) upstream API and key excipient sourcing for manufacturing, and (3) contract manufacturing and packaging partners used by the labeler.

However, “Cordran” is an Rx topical with multiple presentations across markets, and suppliers differ by dosage form (cream, ointment, tape/impregnated tape) and by NDC. Without NDC-level identification for the exact Cordran presentation and market, supplier lists would mix non-equivalent products and risk materially wrong vendor selections.

What companies supply Cordran (flurandrenolide) finished product in the US?

Featured snippet answer: Finished Cordran supply is through the product’s FDA labeler/manufacturer-of-record for each NDC. Supplier-by-supplier mapping must be done at the NDC level.

Cordran supplier mapping must be NDC-specific

Cordran’s supplier landscape changes with:

• Dosage form: cream vs ointment vs tape/impregnated tape
• Strength and pack size
• US labeler (marketing authorization holder in the US FDA system)
• Manufacturer-of-record for each NDC

What to extract for procurement diligence

For any Cordran purchase or vendor onboarding, procurement should capture:

• Labeler name on the FDA NDC Directory (US)
• Manufacturer-of-record for each NDC
• Packaging site (when shown)
• Lot-release testing requirements (quality agreement)

Why generic and store-brand suppliers don’t align 1:1

Even if the same active ingredient (flurandrenolide) is used, suppliers differ by:

• Formulation approach (base selection)
• Tube vs jar vs roll-tape packaging
• Sterility or aseptic status (rare for topical, but packaging and irradiation decisions can differ)
• Manufacturing scale and process development lineage

Who supplies the flurandrenolide API (active pharmaceutical ingredient) used to make Cordran?

Featured snippet answer: Flurandrenolide API supply is through chemical/API manufacturers, but the relevant supplier list depends on the final manufacturer’s commercial supply chain and the specific dosage form.

API sourcing drivers for flurandrenolide

For flurandrenolide, API sourcing is typically constrained by:

• Synthetic route controls and impurity profile
• Salt/solid-state specification (API polymorph and particle size controls)
• Compliance with pharmacopeial and regulatory testing (assay, related substances, residual solvents)

What procurement needs to confirm when talking about “API suppliers”

• DMF or ASMF linkage (if referenced by the finished manufacturer)
• Audit status and GMP scope (API facility certifications)
• Stability program relevance to the dosage form
• Impurity specification limits matched to the finished product

Which contract manufacturing organizations (CMOs) can produce Cordran-style flurandrenolide topicals and tape?

Featured snippet answer: CMO availability for flurandrenolide topicals and tape exists, but the “which CMO supplies Cordran” answer is labeler-dependent and NDC-level.

CMO selection by dosage form

• Cream/ointment: mixing, milling, bulk hold, filling, sealing, and tube or jar packaging
• Tape: adhesive coating, impregnation, cutting/rolling, secondary packaging

Qualification checkpoints for tape manufacturing

Tape manufacturing adds extra controls:

• Adhesive uniformity and release profile
• Mechanical properties (roll diameter, edge integrity)
• Microbial controls for non-sterile products

How do you identify Cordran suppliers from the Orange Book and FDA NDC labeler data?

Featured snippet answer: Use the FDA Orange Book entry for the active ingredient and the FDA NDC Directory for NDC-specific labelers and manufacturer-of-record.

Orange Book is for patents and exclusivity, not vendor procurement

Orange Book helps:

• Identify the active ingredient entry
• Tie product to brand/generic approvals and exclusivity periods
• Support litigation and change-control mapping

FDA NDC Directory is for supplier-of-record discovery

NDC-level manufacturer-of-record is the operational starting point for procurement.

What supplier risk exists if you source generic flurandrenolide under Cordran naming?

Featured snippet answer: Generic entry can shift supply to different manufacturers, and substitution at the pharmacy depends on product code, not the “Cordran” brand name.

Key risks

• Different excipients and base performance
• Different packaging form factor (tube vs tape roll)
• Different compliance histories and recall profiles
• Different manufacturing sites and change-control cadence

Which companies are likely in the supplier chain for Cordran (practical sourcing map)?

Featured snippet answer: Without NDC and presentation, the only actionable “likely” map is structural: the labeler for each NDC contracts or owns (a) an API supply chain and (b) one or more CMO sites for mixing/filling or tape manufacturing.

Structural supplier chain (works for all topical corticosteroids)

1. API supplier (flurandrenolide synthesis manufacturer)
2. Drug product manufacturer (bulk blending and filling)
3. Packaging supplier (tube/jar labeling, and for tape: coating and slitting)
4. Quality control release (finished product testing site)
5. Logistics and distribution (wholesale distributors and specialty channels)

Supply chain alternatives: what to source if Cordran tape or ointment is constrained?

Featured snippet answer: Procurement substitutions should be based on:

• Same active ingredient (flurandrenolide)
• Same strength
• Same dosage form (tape vs cream vs ointment)
• Same or equivalent packaging configuration that matches usage and dosing instructions

Substitution compatibility checklist

• Prescriber instructions (tape application differs from creams/ointments)
• Coverage equivalence (surface area and occlusion effects)
• Formulation base (skin hydration and penetration profile differences)

Key Takeaways

• “Cordran suppliers” must be answered by NDC-level manufacturer-of-record for the exact presentation because suppliers vary by cream/ointment/tape and strength.
• A complete supplier map requires separating finished product labelers/manufacturers from upstream API suppliers and CMOs, which are not interchangeable across dosage forms.
• Procurement-ready due diligence starts with FDA NDC Directory labeler/manufacturer-of-record, then ties into Orange Book for product identity, exclusivity, and change-control context.

FAQs

1. How do I find the manufacturer-of-record for a specific Cordran NDC?
   Use the FDA NDC Directory to extract the labeler and manufacturer-of-record for the exact NDC tied to the presentation and strength.

2. Are flurandrenolide API suppliers the same for cream and tape products?
   Not necessarily. Finished manufacturers often use different commercial supply chains depending on formulation base and manufacturing partner.

3. What supplier documentation should accompany a Cordran procurement lot?
   CoA, CoC, GMP certificate for the manufacturing site, and lot-specific release testing documentation aligned to the product spec.

4. Can pharmacies substitute generic flurandrenolide for Cordran without matching the dosage form?
   Substitution is generally constrained by product code and dosage form; tape cannot be treated as interchangeable with creams/ointments.

5. Where do patent/exclusivity sources help when identifying sourcing risk for Cordran?
   Orange Book helps identify branded/generic approval lineage and exclusivity context, while NDC data identifies current supplier-of-record.

References

1. FDA. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
2. FDA. (n.d.). NDC Directory. U.S. Food and Drug Administration.